Position history for Carlyle Group Inc.'s holdings in SPYRE THERAPEUTICS INC
Carlyle Group Inc. holds 9,620 shares of SYRE (SPYRE THERAPEUTICS INC), worth $485,233 as of 2026-Q1. SYRE represents 0.0% of Carlyle Group Inc.'s portfolio.
Current Value
$485,233
Current Shares
9,620
Total Value Change
+$258,297
Total Shares Change
0
Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP
Unchanged |
| 9,620 |
0.0% |
| $485,233 |
| 0.0% |
| $40.07 |
0 |
| 2025-Q4 | New | 9,620 | - | $315,055 | 0.0% | $31.88 | 36 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $17.94 | 0 |
| 2024-Q4 | Unchanged | 9,620 | 0.0% | $223,761 | 0.0% | $22.54 | 0 |
| 2024-Q3 | Unchanged | 9,620 | 0.0% | $282,443 | 0.0% | $28.49 | 0 |
| 2024-Q2 | Unchanged | 9,620 | 0.0% | $226,936 | 0.0% | $23.51 | 0 |